SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech - Quaterly Results

08 Sep 2021 Evaluate
The company witnessed a 8.49% growth in the revenue at Rs. 1109.56 millions for the quarter ended June 2021 as compared to Rs. 1022.77 millions during the year-ago period.The Total Profit for the quarter ended June 2021 of Rs. 66.87 millions grew from Rs.-226.05 millionsThe company reported a degrowth in operating Profit to 130.74 millions from 145.54 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202106 202006 % Var 202106 202006 % Var 202106 202006 % Var
Sales 1109.56 1022.77 8.49 1109.56 1022.77 8.49 1109.56 1022.77 8.49
Other Income 6.89 6.91 -0.29 6.89 6.91 -0.29 6.89 6.91 -0.29
PBIDT 130.74 145.54 -10.17 130.74 145.54 -10.17 130.74 145.54 -10.17
Interest 4.82 2.54 89.76 4.82 2.54 89.76 4.82 2.54 89.76
PBDT 125.92 -180.51 -169.76 125.92 -180.51 -169.76 125.92 -180.51 -169.76
Depreciation 30.25 29.84 1.37 30.25 29.84 1.37 30.25 29.84 1.37
PBT 95.67 -210.35 -145.48 95.67 -210.35 -145.48 95.67 -210.35 -145.48
TAX 28.80 15.70 83.44 28.80 15.70 83.44 28.80 15.70 83.44
Deferred Tax -0.07 15.70 -100.45 -0.07 15.70 -100.45 -0.07 15.70 -100.45
PAT 66.87 -226.05 -129.58 66.87 -226.05 -129.58 66.87 -226.05 -129.58
Equity 91.04 64.11 42.01 91.04 64.11 42.01 91.04 64.11 42.01
PBIDTM(%) 11.78 14.23 -17.20 11.78 14.23 -17.20 11.78 14.23 -17.20

Windlas Biotech Share Price

865.40 -6.35 (-0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×